Ballentine Partners, LLC Incyte Corp Transaction History
Ballentine Partners, LLC
- $7.1 Billion
- Q3 2025
A detailed history of Ballentine Partners, LLC transactions in Incyte Corp stock. As of the latest transaction made, Ballentine Partners, LLC holds 4,836 shares of INCY stock, worth $503,669. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,836
Previous 4,824
0.25%
Holding current value
$503,669
Previous $328,000
25.0%
% of portfolio
0.01%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding INCY
# of Institutions
809Shares Held
205MCall Options Held
638KPut Options Held
635K-
Baker Bros. Advisors LP New York, NY30.7MShares$3.2 Billion21.24% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$2.22 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$2.08 Billion0.03% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$1.45 Billion0.68% of portfolio
-
State Street Corp Boston, MA9.68MShares$1.01 Billion0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $23.2B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...